Profile data is unavailable for this security.
About the company
Antengene Corporation Limited is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The Company mainly conducts its business in Asia-Pacific.
- Revenue in HKD (TTM)72.63m
- Net income in HKD-627.15m
- Incorporated2018
- Employees201.00
- LocationAntengene Corporation LtdUgland HousePO Box 309SHANGHAI KY1-1104ChinaCHN
- Websitehttps://www.antengene.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uni-Bio Science Group Ltd | 484.72m | 70.88m | 517.74m | 407.00 | 7.54 | 2.08 | 5.90 | 1.07 | 0.0111 | 0.0111 | 0.0762 | 0.0404 | 1.38 | 2.62 | 9.44 | 1,190,953.00 | 20.18 | 1.46 | 28.50 | 1.97 | 81.04 | 80.59 | 14.62 | 1.23 | 1.76 | 97.93 | 0.1796 | -- | 10.08 | 29.08 | 84.04 | -- | -- | -- |
Kintor Pharmaceutical Ltd | 0.00 | -1.14bn | 541.47m | 225.00 | -- | 1.10 | -- | -- | -2.67 | -2.67 | 0.00 | 1.10 | 0.00 | 0.14 | -- | 0.00 | -72.55 | -50.15 | -89.09 | -58.43 | -- | -23.36 | -- | -10,511.41 | 2.10 | -- | 0.3566 | -- | -- | -- | -11.15 | -- | -- | -- |
Clover Biopharmaceuticals Ltd | 42.36m | -149.50m | 564.19m | 387.00 | -- | -- | -- | 13.32 | -0.1197 | -0.1197 | 0.034 | -0.61 | 0.0116 | 0.0098 | 0.7449 | 109,456.30 | -4.08 | -- | -16.40 | -- | 61.75 | -- | -352.92 | -- | 0.5281 | -1.45 | -- | -- | -- | -- | 94.35 | -- | -- | -- |
Tianda Pharmaceuticals Ltd | 532.09m | -24.16m | 580.51m | 863.00 | -- | 0.9805 | 45.61 | 1.09 | -0.0112 | -0.0112 | 0.2475 | 0.2754 | 0.5306 | 4.88 | 4.37 | 616,557.40 | -2.49 | -- | -3.84 | -- | 48.02 | -- | -4.70 | -- | 0.8907 | -10.16 | 0.161 | -- | -- | -- | -- | -- | -- | -- |
Sirnaomics Ltd | 0.00 | -614.79m | 623.99m | 145.00 | -- | 1.99 | -- | -- | -8.08 | -8.08 | 0.00 | 3.58 | 0.00 | -- | -- | 0.00 | -70.91 | -- | -71.22 | -- | -- | -- | -- | -- | -- | -- | 0.6176 | -- | -- | -- | 10.88 | -- | -- | -- |
Genor Biopharma Holdings Ltd | 0.00 | -727.70m | 640.67m | 104.00 | -- | 0.4908 | -- | -- | -1.44 | -1.44 | 0.00 | 2.55 | 0.00 | 0.00 | -- | 0.00 | -37.91 | -55.46 | -44.02 | -63.73 | -- | 66.56 | -- | -14,819.18 | 5.38 | -- | 0.006 | -- | -100.00 | -- | 7.65 | -- | -48.85 | -- |
Fusen Pharmaceutical Co Ltd | 610.34m | -39.15m | 659.96m | 1.15k | -- | 1.08 | 18.37 | 1.08 | -0.0524 | -0.0524 | 0.8116 | 0.8112 | 0.4199 | 1.95 | 4.47 | 531,655.40 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.71 | 0.3797 | -- | 15.02 | 4.13 | -4.83 | -- | -- | -- |
Pak Fah Yeow International Ltd | 259.16m | 105.04m | 660.68m | 102.00 | 6.29 | 0.8634 | 5.88 | 2.55 | 0.337 | 0.337 | 0.8316 | 2.46 | 0.2995 | 2.88 | 22.18 | 2,540,765.00 | 12.14 | 3.99 | 12.60 | 4.18 | 84.45 | 80.79 | 40.53 | 21.27 | 6.90 | 10.08 | 0.0062 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
Lee's Pharmaceutical Holdings Ltd | 1.05bn | 16.70m | 694.83m | 1.06k | 41.61 | 0.3408 | 4.10 | 0.6598 | 0.0284 | 0.0284 | 1.79 | 3.46 | 0.3713 | 1.83 | 10.75 | 996,247.90 | 0.7033 | 13.33 | 0.88 | 17.76 | 52.35 | 61.92 | 1.89 | 36.20 | 0.5526 | 3.90 | 0.0943 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
Antengene Corporation Ltd | 72.63m | -627.15m | 715.38m | 201.00 | -- | 0.5778 | -- | 9.85 | -1.02 | -1.02 | 0.1181 | 1.83 | 0.0358 | 0.9773 | 3.41 | 361,333.20 | -30.91 | -53.57 | -36.46 | -58.94 | 81.74 | -- | -863.51 | -1,987.01 | 6.43 | -- | 0.1491 | -- | -57.97 | -- | 3.38 | -- | -- | -- |
Jbm (Healthcare) Ltd | 610.30m | 97.99m | 717.08m | 258.00 | 7.92 | 0.7646 | 4.82 | 1.17 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
Transcenta Holding Limited | 58.11m | -499.15m | 789.84m | 215.00 | -- | 0.7104 | -- | 13.59 | -1.23 | -1.23 | 0.1428 | 2.55 | 0.0281 | 2.05 | 1.49 | 270,268.70 | -24.17 | -- | -33.97 | -- | 26.74 | -- | -859.01 | -- | 1.20 | -32.87 | 0.285 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
JW (Cayman) Therapeutics Co Ltd | 187.61m | -828.73m | 795.57m | 398.00 | -- | 0.4358 | -- | 4.24 | -2.01 | -2.01 | 0.4559 | 4.41 | 0.0704 | 1.68 | 65.54 | 471,371.40 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.86 | -47.82 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
Zhaoke Ophthalmology Ltd | 20.23m | -415.49m | 830.13m | 313.00 | -- | 0.3756 | -- | 41.03 | -0.7639 | -0.7639 | 0.0372 | 4.05 | 0.0075 | -- | 0.3433 | 64,641.81 | -15.43 | -- | -17.27 | -- | 75.98 | -- | -2,053.54 | -- | 5.32 | -47.54 | 0.1041 | -- | -- | -- | 5.47 | -- | -- | -- |
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 908.10m | 159.93m | 885.20m | 848.00 | 5.53 | 0.5541 | 7.23 | 0.9748 | 0.2855 | 0.2855 | 1.62 | 2.85 | 0.3587 | 2.18 | 2.94 | 1,070,873.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
Brii Biosciences Ltd | 665.80k | -188.66m | 1.01bn | 128.00 | -- | 0.2991 | -- | 1,512.33 | -0.2594 | -0.2594 | 0.0009 | 4.61 | 0.0002 | -- | -- | 5,201.54 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Antengene Corporation Ltd's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 08 Nov 2022 | 20.25m | 3.00% |
Zeal Asset Management Ltd.as of 30 Jun 2023 | 6.32m | 0.94% |
Fidelity Management & Research (Hong Kong) Ltd.as of 08 Nov 2022 | 5.04m | 0.75% |
Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 3.90m | 0.58% |
Fidelity Management & Research (Japan) Ltd.as of 08 Nov 2022 | 3.68m | 0.55% |
Norges Bank Investment Managementas of 31 Dec 2023 | 1.82m | 0.27% |
China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 1.58m | 0.23% |
Amundi (UK) Ltd.as of 29 Feb 2024 | 938.50k | 0.14% |
Dimensional Fund Advisors LPas of 04 Apr 2024 | 692.50k | 0.10% |
American Century Investment Management, Inc.as of 04 Apr 2024 | 111.00k | 0.02% |
More ▼
Data from 30 Sep 2023 - 22 Apr 2024Source: FactSet Research Systems Inc.